t(11;14)(q13;q32) IGH/CCND1

1998-05-01   Jean-Loup Huret  

1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

Clinics and Pathology

Phenotype stem cell origin

B-cell non Hodgkin lymphoma of the low to intermediate grade

Epidemiology

annual incidence 5/106; median age: 65 yrs

Clinics

advanced disease

Prognosis

median survival: 3 to 4 yrs

Phenotype stem cell origin

chronic lymphoproliferative disorder affecting mature B-cells

Epidemiology

rare disease; median age 70 yrs

Clinics

patients often present with advanced stage disease

Prognosis

median survival: 3 yrs

Phenotype stem cell origin

proliferation involving plasma cells

Epidemiology

rare disorder

Prognosis

median survival is less than a yr

Phenotype stem cell origin

chronic B-cell lymphoproliferation

Epidemiology

rare disorder; median age: 70 yrs

Clinics

relatively benign clinical course

Prognosis

80% 5-yr survival

Disease

chronic lymphocytic leukaemia

Phenotype stem cell origin

chronic B-cell lymphoproliferation

Epidemiology

annual incidence 30/106; median age: 60-80 yrs

Clinics

often a slow evolutive disease

Prognosis

highly variable according to the staging: from staging A: survival not reduced compared to age matched population, to staging C: median survival of 2 yrs

Phenotype stem cell origin

malignant plasma cell proliferation (terminally differenciated B-cell)

Epidemiology

annual incidence: 30/106; median age: 60 yrs

Prognosis

median survival: 3 yrs.

Cytogenetics

Cytogenetics morphological

t(11;14) has earlier been thought to be the hallmark of the mantle cell lymphoma; actually, the frequency of t(11;14) is: 50-70% in mantle cell lymphoma, 10-20% in B-prolymphocytic leukaemia, in plasma cell leukaemia, and in splenic lymphoma with villous lymphocytes, and 2-5% in chronic lymphocytic leukaemia, and in multiple myeloma.

Cytogenetics molecular

in particular interphase cytogenetics, are relevant in these diseases with an usually low mitotic index

Additional anomalies

sole anomaly in only 10% of cases; part of a complex karyotype in 2/3 of cases; numerous recurrent anomalies found conjointly (which is the primary?), particularly: +3, +7, del(9p), +18, + mar, found in about 10% of cases each; other: del(1p), del(6q), del(7q), -8, +12, del(13q), del(17p)

Variants

three way complex t(11;14; Var) exist and showed that the crucial event lies on der(14)

Genes Involved and Proteins

Gene name
CCND1 (B-cell leukemia/lymphoma 1)
Location
11q13.3
Dna rna description
5 exons
Protein description
encodes the cyclin D1; role in the cell cycle control: G1 progression and G1/S transition
Gene name
IGH (Immunoglobulin Heavy)
Location
14q32.33

Result of the Chromosomal Anomaly

Description

5 BCL1 translocated on chromosome 14 near JH (junctions genes of IgH) and C in 3; the breakpoint in BCL1 is in MTC (major translocation cluster), centromeric to the gene (in 5), in 80% of cases, or dispersed in mTC1, 2, or 3 in 5of the gene or in the 3 untranslated region of exon 5.no fusion protein, but promoter exchange; the immunoglobulin gene enhancer stimulates the expression of BCL1

Oncogenesis

overexpression of BCL1 accelerates passage through the G1 phase.

Highly cited references

Pubmed IDYearTitleCitations
370481022023The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma.77
420261792026The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.74
349339392022Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers.68
221804802012Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.56
358639002022High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation.47
394173392024The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas.46
393135002024Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.45
380673932023Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells.38
389688472024AL amyloidosis manifesting as a vertebral amyloidoma secondary to an unrecognized plasmacytoma expressing cyclin D1 case report.38
424502282026Molecular Feasibility of Gene Sequencing on Lymph Node Fine-Needle Cytology Samples of Non-Hodgkin Lymphoma.37
380259052023Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14).33
372061912023A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma.32
254357232014Amplification of 1q21 and other abnormalities in multiple myeloma patients from a tertiary hospital in singapore.32
334254122020Synchronous Occurrence of Splenic Pleomorphic Mantle Cell Lymphoma and Esophageal Adenocarcinoma with Overexpression of BCL1 Protein.31
229156502012IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.30
414114842026Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability.29
215081242011Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.28
392848972024Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.27
211202052010Clinical utility of FISH analysis in addition to G-banded karyotype in hematologic malignancies and proposal of a practical approach.27
340746522021Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis.27
274693262016Cyclin D1 expression in peripheral T-cell lymphomas.26
172513352007Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events.24
306274602018Blastoid Variant Mantle Cell Lymphoma Expressing Aberrant CD3 and CD10 with Concurrent Small Lymphocytic Lymphoma: Establishment of a Clonal Relationship by B- and T-Cell Receptor Gene Rearrangements.24
103295981999Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.23
422008272026Leukemic Non-Nodal Mantle Cell Lymphoma Presenting with Traumatic Splenic Rupture.23
348621562023Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion.21
156083912004De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.21
333813292020Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations.20
321505302020Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.20
422268812026Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma.19
420239392026Cutaneous Acral Presentation of Indolent Mantle Cell Lymphoma With Prominent Nail Involvement and Atypical Immunophenotype.19
310152062019Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies.18
370641102023Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing.14
232109242012Conjunctival mass as an initial presentation of mantle cell lymphoma: a case report.14
258594112015Clinicopathologic features of 112 cases with mantle cell lymphoma.11
145147912003Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.10
396912462024Emergence of IGH::CCND1 rearrangement and mutations in TP53, BTK, and BCL2 associated with therapy resistance in chronic lymphocytic leukemia.8
321850612020Anaplastic multiple myeloma resembling dysplastic megakaryocytes.2
417281582026CD45-Positive Small Lymphocyte-Like Myeloma with IGH::CCND1 Fusion and TP53 Mutations.2
380710512023[Comprehensive Diagnosis of Mantle Cell Lymphoma].0
395716912025Cyclin D1-negative mantle cell lymphoma.0
376587752024Superior detection rate of plasma cell FISH using FACS-FISH.0
372498002023Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.0
280387132017Expression of LEF1 in mantle cell lymphoma.0
270152312016Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.0
337271662021CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.0
413399922026Acquired MYC rearrangement potentially associated with ibrutinib resistance in mantle cell lymphoma.0
323860812020Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.0
322245862020[Sequential development of mantle cell lymphoma following chronic lymphocytic leukemia].0
209605632011Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.0
400338482025Semi-Automated Interphase FISH (iFISH) Spot Scoring in CD138-Positive Cells: Validation Study for Genetic Abnormalities Detection in Multiple Myeloma.0
316950022019[Aggressive B-cell lymphoma with IGH/MYC, IGH/BCL2, and IGH/CCND1 translocations].0
366570192023Identification of long noncoding RNA NEAT1 as a key gene involved in the extramedullary disease of multiple myeloma by bioinformatics analysis.0
303177312018[Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].0
295343522018[Clinicopathologic characteristics and prognositic indicators of tonsillar mantle cell lymphoma].0
272411472016[Pathologic characteristics of bone marrow for 
CD5 positive small B cell lymphoma].0
394320922025Cyclin-D1 rearrangement as a secondary event in the large cell transformation of splenic marginal zone lymphoma with a TP53 deletion.0
216118372012Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.0
119725292002Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.0
231141262012[Evaluation of fluorescence in situ hybridization value in detection of chronic lymphocytic leukemia].0
244522042014Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma.0
265867112015Childhood de novo CD5+ Diffuse Large B-cell Lymphoma: a Separate Entity?0
414283182026Mantle cell lymphoma exhibiting repeated progression with the initiation of a JAK-1 inhibitor for psoriatic arthritis.0
129498972003Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma.0
200790112009[Application of interphase fluorescence in situ hybridization in the diagnosis of lymphoma].0
172130262007Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.0
233076012013Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.0
234602682013Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.0
298865842018[Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].0
98657131998High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.0
394247252025MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR.0
183012402008Simultaneous phenotyping and genotyping (FICTION-methodology) on paraffin sections and cytologic specimens: a comparison of 2 different protocols.0
110540682000Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma.0
97390211998Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.0
219159952012Scoring systems in mantle cell lymphoma: a critical point of view.0
316317212020Primary Low-Grade B-Cell Lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes.0
243055392013[Composite lymphoma cosisting of mantle cell lymphoma and follicular lymphoma].0
302952562018[Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].0
420962462026Classic Hodgkin lymphoma with IGH::CCND1 rearrangement: evidence of clonal relation to preceding mantle cell lymphoma.0
383019622024Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.0
305221722018[Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].0
177047432007Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.0
280329142017Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.0
183933242008Automated FISH analysis using dual-fusion and break-apart probes on paraffin-embedded tissue sections.0
214303702011Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximab.0
191271042008[Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].0
211562292010Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.0
174985612007Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes.0
403817012025Optical genome mapping reveals diverse mechanisms of cyclin activation in mantle cell lymphomas lacking IGH::CCND1.0
206337722010Amplification of IGH/CCND1 fusion gene in a primary plasma cell leukemia case.0
223281742012Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories.0
226788042012[Clinical and experimental study of a multiple myeloma case with low hypodiploidy].0
117238172001[Interphase FISH analysis of frozen or fixed tissues for the detection of t(11;14) (q13;q32) in mantle cell lymphoma].0
235818352013Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.0
320358662020MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.0
404073782025Comparison of Immunohistochemistry With Fluorescence In Situ Hybridization for Assessment of CCND1 Rearrangement in Plasma Cell Myeloma.0
182844152009Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.0
162419942005Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma.0
211763602010[Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].0
286416402017[Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].0

Article Bibliography

Pubmed IDLast YearTitleAuthors
94522761998Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.Bosch F et al
90782901997Genes and chromosomes in chronic B-cell leukemia.Crossen PE et al
90782871997Cytogenetics of lymphomas: a brief review of its theoretical and practical significance.Donner LR et al
90812011997Cytogenetics and molecular genetics in multiple myeloma.Feinman R et al
91788311997Prognostic factors in chronic lymphocytic leukemia.Hallek M et al
74974461995Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32).Kobayashi H et al
91788431997Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems.Meusers P et al
87598961996The ultrastructure of mantle cell lymphoma and other B-cell disorders with translocation t(11;14)(q13;q32).Resnitzky P et al
84996401993Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias.Rimokh R et al
92206671997Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32).Shimazaki C et al

Summary

Fusion gene

IGH/CCND1 IGH (14q32.33) CCND1 (11q13.3) M ins(14;11)(q32;q13q13) t(11;14)(q13;q32) t(11;19;14)(q13;q13;q32) t(14;16)(q32;q23) t(14;20)(q32;q12) t(1;11;14)(q32;q13;q32) t(3;14;11)(q21;q32;q13) t(4;14)(p16;q32) t(6;14)(p21;q32)

Note

t(11;14) is mainly found in mantle cell lymphoma, but also in B-prolymphocytic leukaemia, in plasma cell leukaemia, in splenic lymphoma with villous lymphocytes, in chronic lymphocytic leukaemia, and in multiple myeloma, herein briefly described; all these diseases involve a B-lineage lymphocyte.
Atlas Image
t(11;14)(q13;q32) Top: G- banding - Courtesy Diane H. Norback, Eric B. Johnson, Sara Morrison-Delap Cytogenetics at theWaisman Center and R- banding: Third row - Editor; last row and FISH - Courtesy Hossein Mossafa.

Citation

Jean-Loup Huret

t(11;14)(q13;q32) IGH/CCND1

Atlas Genet Cytogenet Oncol Haematol. 1998-05-01

Online version: http://atlasgeneticsoncology.org/haematological/2021/t(11;14)(q13;q32)-igh-ccnd1